Literature Review (Chapter 2)

A tabulated overview of the literature on business cycle convergence and its determinants is provided at the end of this section. In the following paragraphs, we will summarise the main findings of the many-faceted contributions to this strand of research.

[1]  Cornelia M Keck,et al.  Particle size analysis of nanocrystals: improved analysis method. , 2010, International journal of pharmaceutics.

[2]  T. Mayumi,et al.  A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting. , 2004, International journal of pharmaceutics.

[3]  Elaine Merisko-Liversidge,et al.  Nanosizing: a formulation approach for poorly-water-soluble compounds. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  Filippos Kesisoglou,et al.  Nanosizing--oral formulation development and biopharmaceutical evaluation. , 2007, Advanced drug delivery reviews.

[5]  S. Waldman,et al.  Pharmacokinetics of Aprepitant After Single and Multiple Oral Doses in Healthy Volunteers , 2006, Journal of clinical pharmacology.

[6]  Jianfeng Chen,et al.  Preparation and characterization of uniform nanosized cephradine by combination of reactive precipitation and liquid anti-solvent precipitation under high gravity environment. , 2005, International journal of pharmaceutics.

[7]  G. Amidon,et al.  Pharmacokinetics of the CYP 3A Substrate Simvastatin following Administration of Delayed Versus Immediate Release Oral Dosage Forms , 2008, Pharmaceutical Research.

[8]  Qi Shen,et al.  Improvement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancer , 2011, International journal of nanomedicine.

[9]  M. Ghorab,et al.  Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. , 2007, International journal of pharmaceutics.

[10]  B. W. Mϋller,et al.  Particle Size Analysis of Latex Suspensions and Microemulsions by Photon Correlation Spectroscopy , 1984 .

[11]  J. C. Meneghetti,et al.  Plasma kinetics and biodistribution of a lipid emulsion resembling low-density lipoprotein in patients with acute leukemia. , 1994, Cancer research.

[12]  S. Gour,et al.  Manufacturing Nanosized Fenofibrate by Salt Assisted Milling , 2009, Pharmaceutical Research.

[13]  Y. Cohen,et al.  Microstructural characterization of micro- and nanoparticles formed by polymer-surfactant interactions. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[14]  D. Gopinath,et al.  1-O-alkylglycerol stabilized carbamazepine intravenous o/w nanoemulsions for drug targeting in mice , 2007, Journal of drug targeting.

[15]  G. Carlucci,et al.  Simultaneous determination of simvastatin and its hydroxy acid form in human plasma by high-performance liquid chromatography with UV detection. , 1992, Journal of pharmaceutical and biomedical analysis.

[16]  Thomas G. Mason,et al.  Formation of Concentrated Nanoemulsions by Extreme Shear , 2004 .

[17]  C. Washington.  Stability of lipid emulsions for drug delivery , 1996 .

[18]  Hak-Kim Chan,et al.  Feasibility of preparing nanodrugs by high-gravity reactive precipitation. , 2004, International journal of pharmaceutics.

[19]  S. Benita,et al.  Enhanced absorption and drug targeting by positively charged submicron emulsions , 2000 .

[20]  O. Bourdon,et al.  Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. , 2001, Biomaterials.

[21]  Kamalinder K. Singh,et al.  Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine. , 2008, International journal of pharmaceutics.

[22]  H. Teixeira,et al.  Development and characterization of parenteral nanoemulsions containing thalidomide. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[23]  P. Thiagarajan,et al.  Nanoemulsions for drug delivery through different routes , 2011 .

[24]  N. Udupa,et al.  Solid dispersions: a review. , 2009, Pakistan journal of pharmaceutical sciences.

[25]  S. Benita,et al.  Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[26]  Po‐Chang Chiang,et al.  Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studies. , 2008, Journal of pharmaceutical sciences.

[27]  A. Agrawal,et al.  Lipid-based nanosystems and complexes in experimental and clinical therapeutics. , 2005, Current drug delivery.

[28]  M. Gallarate,et al.  Preparation of griseofulvin nanoparticles from water-dilutable microemulsions. , 2003, International journal of pharmaceutics.

[29]  York,et al.  Strategies for particle design using supercritical fluid technologies. , 1999, Pharmaceutical science & technology today.

[30]  Géza Horváth,et al.  Comparison of solid dispersions produced by supercritical antisolvent and spray-freezing technologies. , 2009, International journal of pharmaceutics.

[31]  B. Aungst.  Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. , 1993, Journal of pharmaceutical sciences.

[32]  S. Manickam,et al.  Formulation development and optimization of a novel Cremophore EL-based nanoemulsion using ultrasound cavitation. , 2012, Ultrasonics sonochemistry.

[33]  J. Benoit,et al.  Nano-emulsions and nanocapsules by the PIT method: an investigation on the role of the temperature cycling on the emulsion phase inversion. , 2007, International journal of pharmaceutics.

[34]  M. Ashokkumar,et al.  Minimising oil droplet size using ultrasonic emulsification. , 2009, Ultrasonics sonochemistry.

[35]  Filippos Kesisoglou,et al.  Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[36]  Seid Mahdi Jafari,et al.  Production of sub-micron emulsions by ultrasound and microfluidization techniques , 2007 .

[37]  S. Benita,et al.  Physostigmine emulsion: a new injectable controlled release delivery system , 1986 .

[38]  F. Behar-Cohen,et al.  Topical and intravitreous administration of cationic nanoemulsions to deliver antisense oligonucleotides directed towards VEGF KDR receptors to the eye. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[39]  R. Müller,et al.  Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.

[40]  J. M. Gutiérrez,et al.  Nano-emulsions: New applications and optimization of their preparation , 2008 .

[41]  P. Chattopadhyay,et al.  Production of griseofulvin nanoparticles using supercritical CO(2) antisolvent with enhanced mass transfer. , 2001, International journal of pharmaceutics.

[42]  Kamla Pathak,et al.  Design and development of nanoemulsion drug delivery system of amlodipine besilate for improvement of oral bioavailability , 2011, Drug development and industrial pharmacy.

[43]  D. Craig,et al.  The mechanisms of drug release from solid dispersions in water-soluble polymers. , 2002, International journal of pharmaceutics.

[44]  J. Katz,et al.  Liquid Droplet Dispersions Formed by Homogeneous Liquid−Liquid Nucleation: “The Ouzo Effect” , 2003 .

[45]  Y. Krishnaiah.  Pharmaceutical Technologies for Enhancing Oral Bioavailability of Poorly Soluble Drugs , 2010 .

[46]  H. Teixeira,et al.  Carbamazepine parenteral nanoemulsions prepared by spontaneous emulsification process. , 2007, International journal of pharmaceutics.

[47]  Tushar K. Vyas,et al.  Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations. , 2008, International journal of pharmaceutics.

[48]  D. Burgess,et al.  A novel in vitro release method for submicron-sized dispersed systems , 1999, AAPS PharmSci.

[49]  O. Kayser,et al.  A new approach for targeting to Cryptosporidium parvum using mucoadhesive nanosuspensions: research and applications. , 2001, International journal of pharmaceutics.

[50]  H. Takeuchi,et al.  A combinational supercritical CO2 system for nanoparticle preparation of indomethacin. , 2010, International journal of pharmaceutics.

[51]  Elaine Merisko-Liversidge,et al.  Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. , 2011, Advanced drug delivery reviews.

[52]  Yang Yue,et al.  Preparation and Characterization of a Lecithin Nanoemulsion as a Topical Delivery System , 2009, Nanoscale research letters.

[53]  V. Jain,et al.  Preparation and performance evaluation of saquinavir laden cationic submicron emulsions , 2009, Drug delivery.

[54]  Lowell Gibson,et al.  Lipid-Based Excipients for Oral Drug Delivery , 2007 .

[55]  A. Mahmoud,et al.  Nanoemulsion as a Potential Ophthalmic Delivery System for Dorzolamide Hydrochloride , 2009, AAPS PharmSciTech.

[56]  R. Müller,et al.  Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability. , 2002, International journal of pharmaceutics.

[57]  Jonathan Brown,et al.  Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches. , 2009, International journal of pharmaceutics.

[58]  Shi Cheng Yang,et al.  Preparation and Characterization of Camptothecin Solid Lipid Nanoparticles , 2002, Drug development and industrial pharmacy.

[59]  Samir Z. Wahab,et al.  Development of characterization methods for entacapone in a pharmaceutical bulk. , 2011, Journal of pharmaceutical and biomedical analysis.

[60]  Jeong-Sook Park,et al.  Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. , 2005, International journal of pharmaceutics.

[61]  Dimo Kashchiev,et al.  Nucleation : basic theory with applications , 2000 .

[62]  Dipak K. Sarker.  Engineering of nanoemulsions for drug delivery. , 2005, Current drug delivery.

[63]  R. Maranhão,et al.  Uptake by breast carcinoma of a lipidic nanoemulsion after intralesional injection into the patients: a new strategy for neoadjuvant chemotherapy. , 2009, Gynecologic oncology.

[64]  G. Kulkarni,et al.  Nanoemulsion: A new concept of delivery system , 2010 .

[65]  M. Davies,et al.  The preparation of sub-200 nm biodegradable colloidal particles from poly(β-malic acid-co-benzyl malate) copolymers and their surface modification with Poloxamer and Poloxamine surfactants , 1994 .

[66]  A. Babbar,et al.  Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. , 2008, International journal of pharmaceutics.

[67]  N. Sultana,et al.  Validated spectrophotometric method for quantitative determination of simvastatin in pharmaceutical formulations and human serum , 2007 .

[68]  Jun Li,et al.  Preparation and characterization of intravenously injectable nimodipine nanosuspension. , 2008, International journal of pharmaceutics.

[69]  S. Garg,et al.  Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs. , 2010, Advanced drug delivery reviews.

[70]  P. York,et al.  Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[71]  Helmut Hahn,et al.  Atovaquone Nanosuspensions Show Excellent Therapeutic Effect in a New Murine Model of Reactivated Toxoplasmosis , 2001, Antimicrobial Agents and Chemotherapy.

[72]  R. Müller,et al.  The role of apolipoprotein E in uptake of atovaquone into the brain in murine acute and reactivated toxoplasmosis , 2009, Journal of drug targeting.

[73]  P. Constantinides,et al.  Tocol emulsions for drug solubilization and parenteral delivery. , 2004, Advanced drug delivery reviews.

[74]  J E Kipp,et al.  The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. , 2004, International journal of pharmaceutics.

[75]  M. Goto,et al.  A Novel Solid-in-oil Nanosuspension for Transdermal Delivery of Diclofenac Sodium , 2008, Pharmaceutical Research.

[76]  L. Rizza,et al.  Nanoemulsions as vehicles for topical administration of glycyrrhetic acid: Characterization and in vitro and in vivo evaluation , 2010, Drug delivery.

[77]  C. Rodríguez-Abreu,et al.  Emulsions with structured continuous phases , 2008 .